Shanghai Xuerong Bio-Technology Co Ltd (300511) - Total Assets
Based on the latest financial reports, Shanghai Xuerong Bio-Technology Co Ltd (300511) holds total assets worth CN¥3.61 Billion CNY (≈ $527.99 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shanghai Xuerong Bio-Technology Co Ltd - Total Assets Trend (2012–2024)
This chart illustrates how Shanghai Xuerong Bio-Technology Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Shanghai Xuerong Bio-Technology Co Ltd stock valuation for the company's overall valuation and market capitalisation.
Shanghai Xuerong Bio-Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Shanghai Xuerong Bio-Technology Co Ltd's total assets of CN¥3.61 Billion consist of 14.2% current assets and 85.8% non-current assets. Review 300511 total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 4.4% |
| Accounts Receivable | CN¥31.39 Million | 0.8% |
| Inventory | CN¥325.34 Million | 8.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥299.63 Million | 7.8% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Shanghai Xuerong Bio-Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of Shanghai Xuerong Bio-Technology Co Ltd for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Xuerong Bio-Technology Co Ltd's current assets represent 14.2% of total assets in 2024, an increase from 0.0% in 2012.
- Cash Position: Cash and equivalents constituted 4.4% of total assets in 2024, up from 3.6% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, a decrease from 12.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 8.4% of total assets.
Shanghai Xuerong Bio-Technology Co Ltd Competitors by Total Assets
Key competitors of Shanghai Xuerong Bio-Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
The Grob Tea Company Limited
NSE:GROBTEA
|
India | Rs1.38 Billion |
|
Mowi ASA
OL:MOWI
|
Norway | Nkr10.20 Billion |
|
Oncoinvent ASA
OL:KLDVK
|
USA | Nkr507.79 Million |
|
Heilongjiang Agriculture Co Ltd
SHG:600598
|
China | CN¥15.35 Billion |
|
UIE PLC
CO:UIE
|
Denmark | Dkr1.25 Billion |
|
FAP Agri Tbk PT
JK:FAPA
|
Indonesia | Rp10.34 Trillion |
|
Leshan Giantstar Farming & Husbandry Corp Ltd
SHG:603477
|
China | CN¥9.25 Billion |
|
Shandong Xiantan Co Ltd
SHE:002746
|
China | CN¥8.44 Billion |
Shanghai Xuerong Bio-Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.31 | 0.53 | 1.10 |
| Quick Ratio | 0.08 | 0.27 | 0.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-1.05 Billion | CN¥-780.55 Million | CN¥112.17 Million |
Shanghai Xuerong Bio-Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shanghai Xuerong Bio-Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.08 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -16.2% |
| Total Assets | CN¥3.85 Billion |
| Market Capitalization | $461.38 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Xuerong Bio-Technology Co Ltd's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Shanghai Xuerong Bio-Technology Co Ltd's assets decreased by 16.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)
The table below shows the annual total assets of Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.85 Billion ≈ $564.04 Million |
-16.24% |
| 2023-12-31 | CN¥4.60 Billion ≈ $673.44 Million |
+13.02% |
| 2022-12-31 | CN¥4.07 Billion ≈ $595.87 Million |
-6.18% |
| 2021-12-31 | CN¥4.34 Billion ≈ $635.10 Million |
-4.92% |
| 2020-12-31 | CN¥4.56 Billion ≈ $667.95 Million |
+18.81% |
| 2019-12-31 | CN¥3.84 Billion ≈ $562.18 Million |
-1.30% |
| 2018-12-31 | CN¥3.89 Billion ≈ $569.60 Million |
+1.46% |
| 2017-12-31 | CN¥3.84 Billion ≈ $561.38 Million |
+55.91% |
| 2016-12-31 | CN¥2.46 Billion ≈ $360.06 Million |
+38.64% |
| 2015-12-31 | CN¥1.77 Billion ≈ $259.70 Million |
+14.60% |
| 2014-12-31 | CN¥1.55 Billion ≈ $226.62 Million |
+5.82% |
| 2013-12-31 | CN¥1.46 Billion ≈ $214.15 Million |
+3.79% |
| 2012-12-31 | CN¥1.41 Billion ≈ $206.32 Million |
-- |
About Shanghai Xuerong Bio-Technology Co Ltd
Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, cultivation and sale of fresh edible mushrooms in the People's Republic of China. It offers enoki mushrooms; shiitake mushrooms, including oyster mushrooms, white jade mushrooms and seafood mushrooms; king oyster mushrooms; and velvet mushrooms, as well as Pleurotus eryngii and Flammu… Read more